A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients

BACKGROUND: The use of somatic mutations for predicting clinical outcome is difficult because a mutation can indirectly influence the function of many genes, and also because clinical follow-up is sparse in the relatively young next generation sequencing (NGS) databanks. Here we approach this proble...

Descripción completa

Detalles Bibliográficos
Autores principales: Pongor, Lőrinc, Kormos, Máté, Hatzis, Christos, Pusztai, Lajos, Szabó, András, Győrffy, Balázs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609150/
https://www.ncbi.nlm.nih.gov/pubmed/26474971
http://dx.doi.org/10.1186/s13073-015-0228-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609150/
https://www.ncbi.nlm.nih.gov/pubmed/26474971
http://dx.doi.org/10.1186/s13073-015-0228-1

Ejemplares similares